» Articles » PMID: 36352270

Relapsing and Refractory Peritoneal Dialysis Peritonitis Caused by Corynebacterium Amycolatum

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 2022 Nov 9
PMID 36352270
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Peritonitis is an important complication and cause of morbidity in patients undergoing peritoneal dialysis (PD). Corynebacterium species, often considered skin and mucosal contaminants, are a rare cause of PD-associated peritonitis and have been acknowledged in published guidelines for the diagnosis and treatment of PD peritonitis only over the last decade.

Case-diagnosis/treatment: We present two children with difficult-to-treat episodes of PD peritonitis due to Corynebacterium amycolatum. Episodes were associated with fever, abdominal pain and cloudy dialysate, high dialysate polymorphonuclear leukocyte counts, and elevated serum C-reactive protein and procalcitonin concentrations. Symptoms persisted beyond 5 days in 4 of 5 peritonitis episodes, and peritonitis relapsed despite in vitro sensitivity of the bacterial isolates to guideline-recommended antibiotics. C. amycolatum was cultured from the PD catheter tip despite 4 weeks of intraperitoneal glycopeptide therapy and clinical peritonitis resolution suggestive of efficient biofilm formation. Our systematic literature search identified three previous (adult) case descriptions of C. amycolatum peritonitis, all with repeat episodes by the same organism. The incidence of C. amycolatum as a cause of PD peritonitis has not yet been established but is likely underreported due to challenges in species differentiation.

Conclusions: C. amycolatum is a rarely identified cause of refractory and/or relapsing PD peritonitis. Species differentiation of non-diphtheriae Corynebacterium isolates is critical, and prolonged antibiotic treatment, preferably with a glycopeptide antibiotic, is recommended, with a low threshold for PD catheter change or removal in case of repeat peritonitis.

Citing Articles

Corynebacterium amycolatum peritonitis in a patient undergoing peritoneal dialysis: case report and literature review.

Adil F, Aragon I, Benaissa E, Ben Lahlou Y, Bssaibis F, Maleb A Access Microbiol. 2024; 6(10).

PMID: 39479577 PMC: 11524318. DOI: 10.1099/acmi.0.000880.v3.


The first case of urosepsis caused by in an immunocompetent patient.

Corich L, Losasso C, Meneghel A, Blarasin F, Basaglia G, Corich M Future Microbiol. 2024; 19(11):963-970.

PMID: 39109653 PMC: 11318739. DOI: 10.1080/17460913.2024.2344953.


Persistent peritonitis in peritoneal dialysis: a comphrenesive review of recurrent, relapsing, refractory, and repeat peritonitis.

Wang A, Sawyer K, Shah A Int Urol Nephrol. 2023; 56(2):583-595.

PMID: 37563501 DOI: 10.1007/s11255-023-03731-w.

References
1.
Szeto C, Chow K, Chung K, Kwan B, Leung C, Kam-Tao Li P . The clinical course of peritoneal dialysis-related peritonitis caused by Corynebacterium species. Nephrol Dial Transplant. 2005; 20(12):2793-6. DOI: 10.1093/ndt/gfi123. View

2.
Olender A, Bogut A, Magrys A, Krol-Turminska K . A Novel Approach to Study the Effect of Ciprofloxacin on Biofilms of spp. Using Confocal Laser Scanning Microscopy. Pol J Microbiol. 2018; 67(4):431-440. PMC: 7256825. DOI: 10.21307/pjm-2018-051. View

3.
Warady B, Bakkaloglu S, Newland J, Cantwell M, Verrina E, Neu A . Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update. Perit Dial Int. 2012; 32 Suppl 2:S32-86. PMC: 3524923. DOI: 10.3747/pdi.2011.00091. View

4.
Htay H, Cho Y, Pascoe E, Darssan D, Hawley C, Clayton P . Outcomes of Peritonitis: A Multicenter Registry Analysis. Perit Dial Int. 2017; 37(6):619-626. DOI: 10.3747/pdi.2017.00028. View

5.
De Carvalho R, da Silva Lima F, Santos C, Souza M, Silva R, de Mattos-Guaraldi A . Central venous catheter-related infections caused by Corynebacterium amycolatum and other multiresistant non-diphtherial corynebacteria in paediatric oncology patients. Braz J Infect Dis. 2018; 22(4):347-351. PMC: 9428009. DOI: 10.1016/j.bjid.2018.07.004. View